Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

NCT05876728 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05876728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05876728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
June 1, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer